DOI: 10.1055/s-00022861

Aktuelle Kardiologie

References

Haude M, Erbel R, Erne P et al.
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.

Lancet 2013;
381: 836-844

Download Bibliographical Data

Search in:
Access: